Log in to save to my catalogue

Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis

Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2431817893

Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis

About this item

Full title

Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis

Publisher

Cham: Springer International Publishing

Journal title

Drugs & aging, 2020-10, Vol.37 (10), p.739-746

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Patients with multiple sclerosis exhibit the same qualitative and quantitative changes in immune system cells observed in aging. In the last 20 years, multiple sclerosis patients have shown an increase in life expectancy and average age, but clinical trial inclusion criteria typically exclude patients over the age of 55 years. Therefo...

Alternative Titles

Full title

Age-Related Lymphocyte Output During Disease-Modifying Therapies for Multiple Sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2431817893

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2431817893

Other Identifiers

ISSN

1170-229X

E-ISSN

1179-1969

DOI

10.1007/s40266-020-00789-4

How to access this item